If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £52.20m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Directorate Change

10 Feb 2011 17:32

Investec Structured Products Calculus VCT plc

Directorate Change

Christopher Wightman has today stepped down as a director and as chairman of the Company in order to concentrate on his other business commitments. The board of directors of the Company ("Board") would like to thank Chris for the experience he has brought and the commitment he has made to the Company since its launch. Michael O'Higgins, an existing director of the Company, has been appointed as chairman in his place.

The Board is also pleased to announce the appointment today of Kate Cornish-Bowden as a non-executive director of the Company. Kate brings with her a wealth of experience from her time at Morgan Stanley and the Board welcomes her to the Company.

There are no details required to be disclosed pursuant to paragraphs 9.6.13 (1) to (6) of the Listing Rules.

In light of the change to the constitution of the Board, and in connection with the current offer for subscription of C ordinary shares which opened on 7 January 2011, the Company is in the process of preparing a supplementary prospectus. A further announcement will be made following publication of the supplementary prospectus.

For further enquiries please contact:

Capita Sinclair HendersonCompany SecretaryTel: 01392 477 66610 February 2011

vendor
Date   Source Headline
17th May 20183:48 pmRNSFinal Results
5th Apr 201811:56 amRNSIssue of Equity
4th Apr 20183:20 pmRNSIssue of Equity
11th Jan 20185:53 pmRNSTransaction in Own Shares
9th Jan 20186:02 pmRNSTransaction in Own Shares
3rd Jan 20182:56 pmRNSTransaction in Own Shares
20th Dec 201712:06 pmRNSIssue of Equity
18th Dec 201712:47 pmRNSNet Asset Value(s)
1st Nov 20174:28 pmRNSStatement re Cancellation of Share Premium Account
26th Oct 20179:28 amRNSDirector Declaration
23rd Oct 20173:56 pmRNSHalf-year Report
23rd Oct 20172:12 pmRNSOffer Update
12th Sep 20173:50 pmRNSMerger Results and Issue of Equity
31st Aug 201711:20 amRNSGM Statement
29th Aug 20173:22 pmRNSAGM Statement
16th Aug 20172:06 pmRNSTransfer of ISIN
4th Aug 20175:57 pmRNSFurther re merger
4th Aug 20175:57 pmRNSMerger and Offer for subscription
2nd Aug 20175:46 pmRNSNotice of AGM
1st Aug 20174:05 pmRNSConversion of Securities
25th Jul 201711:16 amRNSDividend Declaration
24th Jul 20174:23 pmRNSStatement re Share Class Merger
4th Jul 201710:57 amRNSDividend Declaration
30th Jun 20174:27 pmRNSNet Asset Value(s)
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
11th May 20176:18 pmRNSAnnual Financial Report
8th May 20174:46 pmRNSChange of Company Registrar
18th Apr 20174:26 pmRNSOfficial List Notice
7th Apr 20172:41 pmRNSIssue of Equity
5th Apr 20175:18 pmRNSIssue of Equity
1st Mar 20174:53 pmRNSIssue of Equity
9th Feb 201711:20 amRNSIssue of Equity
2nd Feb 20174:37 pmRNSResult of Equity Issue
31st Jan 201712:12 pmRNSIssue of Equity
26th Jan 201712:07 pmRNSDividend Declaration
19th Jan 20174:03 pmRNSResult of Meeting
20th Dec 20169:11 amRNSNet Asset Value(s)
25th Nov 20162:16 pmRNSPublication of a Prospectus
24th Oct 201611:30 amRNSIssue of Equity
24th Oct 201611:25 amRNSHalf-year Report
28th Sep 20169:28 amRNSOffer for subscription
26th Jul 20166:18 pmRNSResult of AGM
19th Jul 201610:11 amRNSNet Asset Value(s)
21st Jun 20167:00 amRNSAnnual Financial Report
3rd May 201610:28 amRNSIssue of Equity
27th Apr 20164:14 pmRNSExtension of Closing Date
4th Apr 201610:20 amRNSIssue of Equity
9th Mar 20167:00 amRNSIssue of Equity
26th Feb 20162:47 pmRNSDisclosure of Home Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.